Mucosal barrier agents

Mucosal barrier agents form a protective barrier against acid and pepsin. 

Sucralfate (Carafate) is a mucosal barrier agent and must be administered on an empty stomach for the medication to coat the stomach lining. The nurse should question the time the medication is scheduled for and arrange for the medication to be administered at 0730. 

Sucralfate (Carafate) is a mucosal barrier agent that coats the stomach lining. Protonix does not coat the stomach. 

A mucosal barrier agent to a male client who has peptic ulcer disease. 

At 0900 the breakfast tray should have already been consumed. Administering a mucosal barrier agent after a meal places medication in the stomach that will coat the food, not the stomach lining. This medication should be retimed for 0730 and not administered until later in the morning after the breakfast meal has had a chance to leave the stomach. 

This is the mechanism of action for mucosal barrier agents. 

It is apparent that patients with gluten-induced enteropathy respond to the administration of gluten differently from other people. It is obvious from consideration of the evidence already presented that the reason for this may lie in inadequacy of the small intestinal mucosal barrier. It is clear that the intestinal mucosa or extracts of it will inactivate the deleterious agent(s) in gluten this is a thermolabile reaction, presumably enzymatic in nature. Patients with gluten-induced... 

The CTZ, located outside the blood-brain barrier (BBB), is exposed to cerebrospinal fluid and blood.2,3 Therefore it is easily stimulated by uremia, acidosis, and the circulation of toxins such as chemotherapeutic agents. The CTZ has many serotonin type 3 (5-HT3), neurokinin-1 (NKj), and dopamine (D2) receptors.2 Visceral vagal nerve fibers are rich in 5-HT3 receptors. They respond to gastrointestinal distention, mucosal irritation, and infection. 

The function of the mucosal pellicle is to serve as a barrier between the oral epithelial surface and the external environment, and so it may also act as a barrier to drug delivery. However, there are limited studies assessing the role of the mucus layer in buccal permeability. In one study, treatment of the oral mucosa with anticholinergic agents resulted in an increased permeability of certain compounds, and it was suggested that the reduced salivary flow may have been responsible for the reduced barrier properties of the tissue [113]. In... 

---